1AE:ETR
argenx SE
744,20 €
arrow_upward
+1,89%(+13,80) 1D
12 қаз., 09:56:33 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1AE...
Open
737,80 €
High
744,20 €
Low
737,80 €
Mkt. cap
46,85 млрд
Avg. vol.
78,00
Volume
7,00
P/E ratio
31,67
52-wk high
922,00 €
52-wk low
574,20 €
EPS
23,50 €
No. of employees
2 мың
Open
737,80 €
High
744,20 €
Low
737,80 €
Mkt. cap
46,85 млрд
Avg. vol.
78,00
Volume
7,00
P/E ratio
31,67
52-wk high
922,00 €
52-wk low
574,20 €
EPS
23,50 €
No. of employees
2 мың
News stories
From web sources and news partners
ad-hoc-news.de
·
3 сағат бұрын
Argenx halts UNITY study. Argenx stock trades 1.18 percent higher
ad-hoc-news.de
·
5 сағат бұрын
argenx stock pre-market at EUR 734.10
Yahoo Finance
·
1 күн бұрын
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
AD HOC NEWS
·
2 күн бұрын
Argenx stock sits at EUR 736.30 after a week of mixed trial news
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE